Haoxi Health Technology Ltd Dossier
Qualitative Analysis
Business overview
Haoxi Health Technology Ltd (NASDAQ: HAO) is a Beijing-headquartered online marketing solution provider in China, specializing in serving advertiser clients in the healthcare industry. Incorporated in the Cayman Islands as a holding company, its operations are conducted through its wholly owned indirect PRC subsidiary, Beijing Haoxi Digital Technology Co., Ltd. (Haoxi Beijing). The company offers comprehensive, one-stop online marketing solutions, with a particular focus on online short video marketing. Its services encompass the planning, production, placement, and optimization of online ads, helping healthcare advertisers acquire, convert, and retain consumers on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi utilizes its proprietary data analysis software, "Bidding Compass", to enhance ad placement strategies and reduce costs for its clients.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Launched customized livestreaming agency services through its subsidiary, Beijing Haoxi Digital Technology Co., Ltd., targeting the 'light medical aesthetics' segment (such as laser and injection-based treatments). The service provides a full-cycle, closed-loop approach covering account setup, content planning, short video marketing, livestream ad strategy, and platform resource integration.
Expected impact: Captures growing demand for interactive commerce in the healthcare and medical aesthetics sectors, diversifying the company's service offerings beyond traditional news feed ads.
Integration of the Gausspeed generative AI platform into Haoxi's marketing application scenarios through a strategic partnership with Gauss Intelligence.
Expected impact: Enhances content production efficiency, automates creative content generation, and improves intelligent decision-making processes for digital marketing campaigns targeting healthcare advertisers.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
A three-year agreement to jointly commit R&D, data, and channel resources to launch an AI-powered health management platform in China, marking Haoxi's entry into the AI healthcare and digital therapeutics track.
Terms: The collaboration covers intelligent nutrition, chronic disease risk assessment, and digital therapeutics, with Eaglepoint handling model iteration and data-security compliance.
Aims to combine the Gausspeed generative AI platform with Haoxi's marketing application scenarios to enhance big data analysis and automate creative content generation.